Connect with us
SpliceBio raised $135 million in a Series B round led by EQT Life Sciences and Sanofi Ventures, with support from major biotech investors. The funding will...
3A Biotech introduces Tocotyrosol and Bioprotec RT—natural, multifunctional ingredients enhancing food stability, safety, and health. Tocotyrosol offers antioxidant and health benefits, while Bioprotec RT provides antimicrobial...
María Río (Gilead) and Marina Pollán (ISCIII) formalized the 12th Gilead Biomedical Research Grants, Spain’s top pharma-sponsored R&D initiative. It supports HIV, oncology, and now PrEP...
Researchers developed a highly sensitive (99%) liquid biopsy blood test to detect HPV-related head and neck cancers. By identifying circulating tumor DNA post-surgery, it enables early...
Researchers developed CAR-STAb, a new immunotherapy combining CAR-T cells and bispecific antibodies, showing promise against B-cell malignancies in animal models. It recruits additional immune cells, blocking...
Spain’s health ministry has approved funding for Tofersen (Qalsody), the first EU-approved drug targeting a genetic cause of ALS—SOD1 mutations. This personalized therapy silences the gene...
Barcelona hosts the KRAS Think Tank Meeting, uniting global experts to share cutting-edge research on the KRAS oncogene, mutated in many cancers. Led by Dr. Rafael...
In 2024, Spain’s pharmaceutical industry surpassed €1.5 billion in R&D investment, emphasizing clinical research and collaborations beyond universities. Nearly 45% of projects involve hospitals and research...
Bladder cancer treatment has advanced significantly, doubling survival in some stages. In Spain, experts urge improved access and multidisciplinary care. The II Bladder Cancer Conference stressed...
The European Commission launched a public consultation on the EU Biotechnology Law, aiming to boost competitiveness and safety in the biotech sector. Open until June 11,...
 |
|
 |  |
 |
|